GALT insider buying
Every open-market purchase of Galectin Therapeutics Inc (GALT) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$19.52K
Insiders buying (12m)1
Purchases on record1
Last purchase filedDec 23, 2025
In the last 12 months, 1 insider of Galectin Therapeutics Inc bought $19.52K of GALT stock on the open market in 1 reported purchase. The most recent was filed on Dec 23, 2025: Freeman Kevin D (Director) bought 5,500 shares at $3.55, worth $19.52K. 1 of these trades were pre-scheduled under a Rule 10b5-1 plan.
Get the next GALT insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll GALT insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Dec 23 | Freeman Kevin D10b5-1Director | $19.52K | 5,500 | $3.55 | +11% | Dec 23 | SEC |